Shire's Lawsuit Against Nostrum Moves Forward After Judge Denies Motion

Law360 (July 18, 2005, 12:00 AM EDT) -- A federal judge in New Jersey has denied Nostrum Pharmaceuticals’ motion for summary judgment in Shire Pharmaceuticals Group’s patent infringement lawsuit over Nostrum’s plans to make a generic version of the epilepsy treatment Carbatrol.

Judge Mary Little Cooper’s ruling means that the lawsuit between Shire and Nostrum will continue to move toward trial. No trial date has been set by the court at this time, Shire said.

In addition to continuing the litigation between Shire and Nostrum, the court's ruling has the effect of maintaining the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.